Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members and maintain the reputation of the sector.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Change Manager / Organisational Impact Lead

We’re looking for an experienced and people-focused Change Manager to help drive successful change across our portfolio. This is an exciting opportunity to join a brand-new team and shape how change is delivered, adopted, and sustained, ensuring our initiatives achieve meaningful, measurable impact across the organisation.

About the Role

Sitting within the Portfolio Delivery Office (PDO), you will lead and embed effective change management across major initiatives.

You will:

Project Manager (Life Cycle / Minor Works)

The Babraham Research Campus is a world class hub where pioneering bioscience companies grow, collaborate and thrive. Set within 430 acres of beautiful parkland, the campus brings together cutting-edge science facilities, exceptional workspaces, and a vibrant community of innovators.

Role:

An opportunity to join a growing Campus at the heart of the Cambridge Biotech cluster. As part of the PPM/Engineering team, this role will focus on the management of life cycle and minor works projects across the property portfolio of our business with a value of up to £500K.

Cancer Research Horizons makes one of the largest oesophageal cancer datasets available for commercial licensing 

Cancer Research Horizons, the innovation engine of Cancer Research UK, is proud to announce the addition of the Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) study dataset to its growing portfolio of commercially licensable data assets.

Research Associate/Senior Research Associate

About the Company

T-Therapeutics is a venture-backed company on a mission to unlock the power of T cells to treat chronic and infectious diseases.

Based on technology from Professor Allan Bradley’s laboratory in Cambridge University’s Department of Medicine, T-Therapeutics has secured significant investment from a blue-chip syndicate of investors to support its drug discovery efforts and prepare candidates for clinical development.

Operations Manager - Operations

We are a fast-growing biotech start-up focusing on next-generation precision biologics, driven by science, collaboration, and curiosity. We are looking for an Operations Manager to lead the day-to-day operational delivery of the company’s operations, laboratory, and infrastructure processes, ensuring effective execution in line with governance set by the Head of Operations.

Harness Therapeutics Nominates HRN001, a First-in-Class Drug Candidate for Huntington’s Disease and Establishes Clinical Advisory Board

- HRN001 is a potent and specific antisense oligonucleotide designed to drive controlled upregulation of FAN1, a genetically validated target in Huntington’s disease

- Clinical Advisory Board formed to support progression of HRN001 into first-in-human studies in 2027

- Dr Andy Billinton, CSO will present preclinical data at the upcoming CHDI Foundation Huntington’s Disease Therapeutics Conference

Subscribe to